anonymous
Guest
anonymous
Guest
Company continuing to waste money with charity sponsorships when the ship is sinking. Great evidence for law suit. Thank u
Little Dicky does delirium.Company continuing to waste money with charity sponsorships when the ship is sinking. Great evidence for law suit. Thank u
Little Dicky does duplicity.Trial results will most definitely readout 202#
No one will do it. They’re not that stupid.Whatever investment bank funds us to get to there read out will have to be the dumbest bunch of bankers on the planet.
The market is loving the update. Stock down 8 percent today.another vacant and hallow presentation by the clown show. They tiptoed past the the most important question while leaving the new, ill-equiped cfo sidelined: "how do you get to phase 3 readouts when you run out of funds by OCT 25 ?" ALL the tss 50 vs absolute tss dont mean jack shit if you cant get to readouts. At least the trip wasn't a total loss; The belly dancer was able to pick up a nice prada bag and a bunch of shiny new gold bracelets and necklaces. The cfo carried her bags for her.
I think he meant he likes to be disciplined. Make it hurt baby!The laughable yet pathetic line of the day from our own in house weasel, “we continue to be disciplined” lol then why don’t we have money to get to 3 phase 3 readouts ? Lmfao. That’s like basic class 101. You did three debt deals paying a friggin arm and a leg and you couldn’t get us there. You suck. Go back to Canada.
He had zero relevant experience for this role. Why would anyone think the outcome would be different? He worked with massive brands that sold themselves. His skill set is managing his career. That is it. He is not well educated, he is not an intellectual, nor is he a likable, inspirational leader. People, other than is lackey hangers on, could not stand him at Amgen and Ipsen. So the question remains...why him? The BOD is grossly negligent in appointing him to this position. They should and will be sued personally for their negligence.Here's Why Shareholders May Want To Be Cautious With Increasing Karyopharm Therapeutics Inc.'s (NASDAQ:KPTI) CEO Pay Packet - Simply Wall St News
Here's Why Shareholders May Want To Be Cautious With Increasing Karyopharm Therapeutics Inc.'s (NASDAQ:KPTI) CEO Pay Packet
Key Insights
- Karyopharm Therapeutics' Annual General Meeting to take place on 28th of May
- CEO Richard Paulson's total compensation includes salary of US$769.6k
- The overall pay is 47% above the industry average
- Karyopharm Therapeutics' three-year loss to shareholders was 94% while its EPS grew by 28% over the past three years
Who is this “belly dancer”?The market is loving the update. Stock down 8 percent today.
It means, the company will lose 99 percent of its value in short order. The report card is printed business day at 4pm. Nothing can hide, obfuscate, nor delude that reality.What does it mean when the least capable, intelligent and competent person in an organization leads that organization?